Healthcare and Medical

home | healthcare and medical | market report

£8,000.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

Emerging markets series - Benchmarking key countries Brazil, Russia, India, China and Turkey (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 09/01/2008
  • Report Title: Emerging markets series - Benchmarking key countries Brazil, Russia, India, China and Turkey
  • Table of Contents: View Table of Contents
  • Report Type: Market Report
  • Country: Global
  • Number of Pages: 407
Introduction

With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market countries in order to sustain their revenue growth. While some countries, with double digit growth rates present tremendous opportunities, there are also many obstacles that need to be overcome.

Scope

  • Review of the key macroeconomic trends and business environment in analyzed countries
  • In-depth analysis of the healthcare system dynamics in key emerging markets
  • Analysis of the pharmaceutical market dynamics in analyzed emerging markets
  • Overview of the outsourcing opportunities for key emerging markets


  • Highlights

    Fast economic growth, increasing economic and political stability coupled with tremendous patient potential and increased Westernization of lifestyle present new opportunities for global pharmaceutical companies. Despite problematic intellectual property protection high market potential is attracting most multinational pharmaceutical companies.

    Healthcare system characteristics differ greatly between different emerging market countries. Greater state participation in healthcare provision is observed in all markets although growing disposable income and out-of-pocket expenditure are contributing to market growth.

    The changing medical needs of the emerging countries are favoring multinational companies: sales of anti-infective agents are slowing down and cancer drugs, immunomodulatory and respiratory drugs among others are growing at fast rates. With increasing purchasing power consumer preference for expensive new treatments is growing.

    Reasons to Purchase

  • Identify the key trends that are driving and resisting the growth of the pharmaceutical market in key developing countries
  • Understand the macroeconomic factors and healthcare system characteristics impacting the pharmaceutical market in the analyzed countries
  • Gain insight into current market dynamics and opportunities and challenges for foreign companies wishing to enter these emerging markets
  • £8,000.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic